Next-generation Implants Market

Executive Summary

Next-generation Implants Market was valued at US $28.25 billion in 2021 and is projected to grow at 5.49% CAGR over the forecast period to reach US $38.93 billion by 2027. Next-generation Implants Market represented US $2.86 billion opportunity over 2019-2021 and estimated to create US $10.68 billion opportunity in 2027 over 2021.

Next-generation Implants from Consainsights analyses the Next-generation Implants Market in the Life Sciences industry over the forecast period to 2027.

Next-generation Implants research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Next-generation Implants segmentation includes Application, Material, End User and Geography.

Based on the Application, the Next-generation Implants analysis covers Orthopedic Implants, Cardiovascular Implants, Ocular Implants, Dental Implants, Other Applications.

In Application segment, Orthopedic Implants segment has highest cagr growth of 4.86%.

Based on the Material, the Next-generation Implants analysis covers Metals and Metal Alloys, Ceramics, Polymers, Biologics, Other Materials.

In Material segment, Metals and Metal Alloys segment has highest cagr growth of 4.86%.

Based on the End User, the Next-generation Implants analysis covers Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Academic and Research Institutes.

In End User segment, Hospitals segment has highest cagr growth of 4.86%.

Based on the region, the Next-generation Implants analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Abbott Laboratories, Smith & Nephew PLC, Johnson & Johnson, Boston Scientific Corporation, C.R. Bard Inc., Medtronic PLC, Wright Medical Group NV, Stryker Corporation, Globus Medical Inc., DENTSPLY SIRONA Inc., Zimmer Biomet Holdings Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Application

Introduction

In 2021, Orthopedic Implants segment has the highest revenue of US $11.03 billion and is expected to grow at CAGR of 4.86% by 2027 Orthopedic Implants segment has highest cagr growth of 4.86%.

Orthopedic Implants

Orthopedic Implants segment was valued at US $9.91 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $15.20 billion by 2027. Orthopedic Implants segment represented US $1.12 billion opportunity over 2019-2021 and estimated to create US $4.17 billion opportunity in 2027 over 2021.

Cardiovascular Implants

Cardiovascular Implants segment was valued at US $7.50 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $11.51 billion by 2027. Cardiovascular Implants segment represented US $0.85 billion opportunity over 2019-2021 and estimated to create US $3.16 billion opportunity in 2027 over 2021.

Ocular Implants

Ocular Implants segment was valued at US $3.94 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $6.04 billion by 2027. Ocular Implants segment represented US $0.44 billion opportunity over 2019-2021 and estimated to create US $1.66 billion opportunity in 2027 over 2021.

Dental Implants

Dental Implants segment was valued at US $2.23 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $3.42 billion by 2027. Dental Implants segment represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $0.94 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $1.79 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $2.75 billion by 2027. Other Applications segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $0.75 billion opportunity in 2027 over 2021.

Material

Introduction

In 2021, Metals and Metal Alloys segment has the highest revenue of US $11.85 billion and is expected to grow at CAGR of 4.86% by 2027 Metals and Metal Alloys segment has highest cagr growth of 4.86%.

Metals and Metal Alloys

Metals and Metal Alloys segment was valued at US $10.65 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $16.33 billion by 2027. Metals and Metal Alloys segment represented US $1.20 billion opportunity over 2019-2021 and estimated to create US $4.48 billion opportunity in 2027 over 2021.

Ceramics

Ceramics segment was valued at US $7.28 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $11.16 billion by 2027. Ceramics segment represented US $0.82 billion opportunity over 2019-2021 and estimated to create US $3.06 billion opportunity in 2027 over 2021.

Polymers

Polymers segment was valued at US $4.43 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $6.79 billion by 2027. Polymers segment represented US $0.50 billion opportunity over 2019-2021 and estimated to create US $1.86 billion opportunity in 2027 over 2021.

Biologics

Biologics segment was valued at US $1.64 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $2.52 billion by 2027. Biologics segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $0.69 billion opportunity in 2027 over 2021.

Other Materials

Other Materials segment was valued at US $1.39 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $2.13 billion by 2027. Other Materials segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.58 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $14.18 billion and is expected to grow at CAGR of 4.86% by 2027 Hospitals segment has highest cagr growth of 4.86%.

Hospitals

Hospitals segment was valued at US $12.74 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $19.54 billion by 2027. Hospitals segment represented US $1.44 billion opportunity over 2019-2021 and estimated to create US $5.36 billion opportunity in 2027 over 2021.

Ambulatory Surgical Centers

Ambulatory Surgical Centers segment was valued at US $5.16 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $7.91 billion by 2027. Ambulatory Surgical Centers segment represented US $0.58 billion opportunity over 2019-2021 and estimated to create US $2.17 billion opportunity in 2027 over 2021.

Orthopedic Clinics

Orthopedic Clinics segment was valued at US $3.25 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $4.99 billion by 2027. Orthopedic Clinics segment represented US $0.37 billion opportunity over 2019-2021 and estimated to create US $1.37 billion opportunity in 2027 over 2021.

Academic and Research Institutes

Academic and Research Institutes segment was valued at US $4.23 billion in 2019 and is projected to grow at 4.86% CAGR over the forecast period to reach US $6.49 billion by 2027. Academic and Research Institutes segment represented US $0.48 billion opportunity over 2019-2021 and estimated to create US $1.78 billion opportunity in 2027 over 2021.